Prostatic disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Abnormal increase of PSA value by laboratory examination 2: Prostate cancer screening patients 3: Patients with clinical symptoms of prostate disease 4: Examination 6 weeks before without puncture biopsy technique 5: Patients with no contraindications to MRI examination
Exclusion criteria
Exclusion criteria: 1: Other treatments, such as endocrine therapy, chemoradiotherapy, etc., were performed before MRI examination 2: A needle biopsy was performed prior to MRI examination 3: Patients with claustrophobia and very limited mobility 4: The image artifact is heavy and difficult to evaluate 5: Patients who did not see obvious suspicious lesions on DWI images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCR CNR; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADC value;Image quality evaluation;PI-RADS score; | — |
Countries
China
Contacts
No. 1, Huang he West Road, Huai yin District, Huai'an City, Jiangsu Province